Yuanqing Mao Selected Research

Infections

1/2014

Risk factors for periprosthetic joint infection after total hip arthroplasty and total knee arthroplasty in Chinese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanqing Mao Research Topics

Disease

5	Developmental Dysplasia of the Hip 01/2017 - 03/2014
4	Osteolysis 01/2022 - 03/2009
3	Neoplasms (Cancer) 07/2022 - 01/2020
3	Pain (Aches) 06/2022 - 01/2013
2	Osteoarthritis 06/2022 - 01/2013
2	Bone Resorption 01/2022 - 01/2020
2	Osteophyte 09/2021 - 12/2014
1	Synovitis 06/2022
1	Osteosarcoma (Osteogenic Sarcoma) 09/2021
1	Hypoxia (Hypoxemia) 09/2021
1	Inflammation (Inflammations) 01/2020
1	Osteonecrosis (Kienbock's Disease) 02/2018
1	Paralysis (Palsy) 01/2017
1	Hip Dislocation 01/2017
1	Congenital Abnormalities (Deformity) 01/2017
1	Contracture 01/2015
1	Leg Length Inequality 01/2015
1	Infections 01/2014
1	Arthralgia (Joint Pain) 01/2013

Drug/Important Bio-Agent (IBA)

3	TitaniumIBA 01/2022 - 11/2014
2	Pharmaceutical PreparationsIBA 07/2022 - 01/2022
2	polydopamineIBA 07/2022 - 09/2021
2	CopperIBA 07/2022 - 01/2020
2	LigandsIBA 01/2022 - 01/2020
1	AntioxidantsIBA 07/2022
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 07/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Glutathione (Reduced Glutathione)IBA 07/2022
1	IonsIBA 07/2022
1	HydrogelsIBA 06/2022
1	PapainIBA 06/2022
1	Metalloproteases (Metalloproteinases)IBA 06/2022
1	NF-kappa B (NF-kB)IBA 06/2022
1	Hyaluronic Acid (Hyaluronan)IBA 06/2022
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 01/2022
1	UiO-66IBA 09/2021
1	Tirapazamine (SR 4233)IBA 09/2021
1	perfluorotributylamine (FC 43)IBA 09/2021
1	Oxygen (Dioxygen)IBA 09/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	magnoflorineIBA 01/2020
1	aporphineIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AlkaloidsIBA 01/2020
1	CytokinesIBA 01/2020
1	artemisinin-naphthoquine combinationIBA 02/2018
1	naringeninIBA 11/2014
1	Iodoacetic AcidIBA 01/2013
1	Calcitonin Gene-Related PeptideIBA 01/2013
1	Glial Fibrillary Acidic ProteinIBA 01/2013
1	CalciumIBA 01/2013
1	VIVIT peptideIBA 03/2009

Therapy/Procedure

9	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2021 - 01/2014
4	Prostheses and Implants (Prosthesis) 01/2022 - 11/2014
3	Therapeutics 07/2022 - 01/2020
2	Injections 06/2022 - 01/2013
2	Photothermal Therapy 09/2021 - 01/2020
1	Intra-Articular Injections 06/2022
1	Lasers (Laser) 01/2020
1	Nanospheres 01/2020
1	Extracorporeal Shockwave Therapy 02/2018
1	Osteotomy 01/2017
1	Arthroplasty 11/2014
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2014